Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
Clinical trial NCT06048133 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06048133
- Sponsor
- Nataliya Uboha
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-08
- Primary completion
- 2026-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.